FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178746109> ?p ?o ?g. }

• W3178746109 endingPage "e2117128" @default.
• W3178746109 startingPage "e2117128" @default.
• W3178746109 abstract "Emergency departments (EDs) sporadically use a high-dose buprenorphine induction strategy for the treatment of opioid use disorder (OUD) in response to the increasing potency of the illicit opioid drug supply and commonly encountered delays in access to follow-up care.To examine the safety and tolerability of high-dose (>12 mg) buprenorphine induction for patients with OUD presenting to an ED.In this case series of ED encounters, data were manually abstracted from electronic health records for all ED patients with OUD treated with buprenorphine at a single, urban, safety-net hospital in Oakland, California, for the calendar year 2018. Data analysis was performed from April 2020 to March 2021.ED physicians and advanced practice practitioners were trained on a high-dose sublingual buprenorphine induction protocol, which was then clinically implemented.Vital signs; use of supplemental oxygen; the presence of precipitated withdrawal, sedation, and respiratory depression; adverse events; length of stay; and hospitalization during and 24 hours after the ED visit were reported according to total sublingual buprenorphine dose (range, 2 to >28 mg).Among a total of 391 unique patients (median [interquartile range] age, 36 [29-48] years), representing 579 encounters, 267 (68.3%) were male and 170 were (43.5%) Black. Homelessness (88 patients [22.5%]) and psychiatric disorders (161 patients [41.2%]) were common. A high dose of sublingual buprenorphine (>12 mg) was administered by 54 unique clinicians during 366 (63.2%) encounters, including 138 doses (23.8%) greater than or equal to 28 mg. No cases of respiratory depression or sedation were reported. All 5 (0.8%) cases of precipitated withdrawal had no association with dose; 4 cases occurred after doses of 8 mg of buprenorphine. Three serious adverse events unrelated to buprenorphine were identified. Nausea or vomiting was rare (2%-6% of cases). The median (interquartile range) length of stay was 2.4 (1.6-3.75) hours.These findings suggest that high-dose buprenorphine induction, adopted by multiple clinicians in a single-site urban ED, was safe and well tolerated in patients with untreated OUD. Further prospective investigations conducted in multiple sites would enhance these findings." @default.
• W3178746109 created "2021-07-19" @default.
• W3178746109 creator A5001033111 @default.
• W3178746109 creator A5003683069 @default.
• W3178746109 creator A5025601376 @default.
• W3178746109 creator A5029525341 @default.
• W3178746109 creator A5030966229 @default.
• W3178746109 creator A5035244423 @default.
• W3178746109 creator A5050421558 @default.
• W3178746109 creator A5053895234 @default.
• W3178746109 creator A5070571474 @default.
• W3178746109 creator A5087916122 @default.
• W3178746109 date "2021-07-15" @default.
• W3178746109 modified "2023-10-17" @default.
• W3178746109 title "High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder" @default.
• W3178746109 cites W1990024777 @default.
• W3178746109 cites W1992389336 @default.
• W3178746109 cites W2018914766 @default.
• W3178746109 cites W2038802102 @default.
• W3178746109 cites W2040327352 @default.
• W3178746109 cites W2056888894 @default.
• W3178746109 cites W2060537745 @default.
• W3178746109 cites W2072398487 @default.
• W3178746109 cites W2093274439 @default.
• W3178746109 cites W2151493975 @default.
• W3178746109 cites W2158292788 @default.
• W3178746109 cites W2159966592 @default.
• W3178746109 cites W2163889626 @default.
• W3178746109 cites W2594272477 @default.
• W3178746109 cites W2604185978 @default.
• W3178746109 cites W2730179692 @default.
• W3178746109 cites W2736907273 @default.
• W3178746109 cites W2792858351 @default.
• W3178746109 cites W2906102371 @default.
• W3178746109 cites W2906757530 @default.
• W3178746109 cites W2946056695 @default.
• W3178746109 cites W2964194900 @default.
• W3178746109 cites W2967830356 @default.
• W3178746109 cites W2978952282 @default.
• W3178746109 cites W3001657010 @default.
• W3178746109 cites W3005090776 @default.
• W3178746109 cites W3022703591 @default.
• W3178746109 cites W3022769978 @default.
• W3178746109 cites W3084351371 @default.
• W3178746109 cites W3086036271 @default.
• W3178746109 cites W3090555497 @default.
• W3178746109 cites W3092920584 @default.
• W3178746109 cites W3139513491 @default.
• W3178746109 cites W4230756955 @default.
• W3178746109 cites W4243617140 @default.
• W3178746109 cites W4246168315 @default.
• W3178746109 cites W4246989716 @default.
• W3178746109 cites W4255060065 @default.
• W3178746109 doi "https://doi.org/10.1001/jamanetworkopen.2021.17128" @default.
• W3178746109 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8283555" @default.
• W3178746109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34264326" @default.
• W3178746109 hasPublicationYear "2021" @default.
• W3178746109 type Work @default.
• W3178746109 sameAs 3178746109 @default.
• W3178746109 citedByCount "50" @default.
• W3178746109 countsByYear W31787461092021 @default.
• W3178746109 countsByYear W31787461092022 @default.
• W3178746109 countsByYear W31787461092023 @default.
• W3178746109 crossrefType "journal-article" @default.
• W3178746109 hasAuthorship W3178746109A5001033111 @default.
• W3178746109 hasAuthorship W3178746109A5003683069 @default.
• W3178746109 hasAuthorship W3178746109A5025601376 @default.
• W3178746109 hasAuthorship W3178746109A5029525341 @default.
• W3178746109 hasAuthorship W3178746109A5030966229 @default.
• W3178746109 hasAuthorship W3178746109A5035244423 @default.
• W3178746109 hasAuthorship W3178746109A5050421558 @default.
• W3178746109 hasAuthorship W3178746109A5053895234 @default.
• W3178746109 hasAuthorship W3178746109A5070571474 @default.
• W3178746109 hasAuthorship W3178746109A5087916122 @default.
• W3178746109 hasBestOaLocation W31787461091 @default.
• W3178746109 hasConcept C118552586 @default.
• W3178746109 hasConcept C119060515 @default.
• W3178746109 hasConcept C126322002 @default.
• W3178746109 hasConcept C139719470 @default.
• W3178746109 hasConcept C162324750 @default.
• W3178746109 hasConcept C170493617 @default.
• W3178746109 hasConcept C194828623 @default.
• W3178746109 hasConcept C197934379 @default.
• W3178746109 hasConcept C2776814716 @default.
• W3178746109 hasConcept C2776867660 @default.
• W3178746109 hasConcept C2776890885 @default.
• W3178746109 hasConcept C2778375690 @default.
• W3178746109 hasConcept C2778949969 @default.
• W3178746109 hasConcept C2779418921 @default.
• W3178746109 hasConcept C2780724011 @default.
• W3178746109 hasConcept C2781063702 @default.
• W3178746109 hasConcept C42219234 @default.
• W3178746109 hasConcept C71924100 @default.
• W3178746109 hasConceptScore W3178746109C118552586 @default.
• W3178746109 hasConceptScore W3178746109C119060515 @default.
• W3178746109 hasConceptScore W3178746109C126322002 @default.
• W3178746109 hasConceptScore W3178746109C139719470 @default.
• W3178746109 hasConceptScore W3178746109C162324750 @default.

• next